AHA: AstraZeneca, Moderna shine early light on mRNA potential in heart failure AHA: Bristol Myers' $13B MyoKardia heart drug gets along with beta blockers as clock ticks down to FDA decision 2021's Fiercest Women in Life Sciences Sponsored: Tips on building a resilient cGMP chemical supply chain Protagonist posts phase 2 hormone replacement data, pitching for lead role in genetic iron overload disease Sponsored: Considerations for Laboratory-Related Operational and Patient Burden in Decentralized Clinical Trials. Clinical Lab Testing in Your Home: Fact or Fiction? Twist spins out COVID-19 antibody program, forming startup to advance variant-busting candidate Scientific co-founder of Blueprint Medicines launches Recludix with $60M, 15-year Seagen exec steering the ship Abbott's retrievable, leadless pacemaker clears trial hurdle as FDA continues review CMS rescinds Trump-era rule expediting Medicare coverage of breakthrough devices Injectable 'dancing molecules' repair spinal cord injury, restore mobility in paralyzed mice Featured Story | By Ben Adams Although AstraZeneca and Moderna are archrivals in the COVID-19 vaccine space, the two have an interesting mRNA pact that has been operating largely under the radar. read more |
| |
|---|
|
Top Stories By Annalee Armstrong Turns out Bristol Myers Squibb’s targeted heart drug mavacamten gets along pretty well with traditional beta blocker therapies that are often used to control blood pressure. This is key as BMS pads the case for an approval of the therapy picked up through the $13 billion acquisition of MyoKardia just over a year ago. read more By Annalee Armstrong “It took a village to make me.” These words spoken by WeiQing Zhou, who is the cofounder of two biotechs, could apply to almost any of the women on the 2021 Fiercest Women in Life Sciences list. read more Sponsored by: Thermo Fisher Scientific Plan for growth and meeting patient demand with cGMP supply chain expert tips on sourcing, mitigating risks, and partner selection from Thermo Fisher Scientific Production Chemicals and Services. read more By Nick Paul Taylor Protagonist Therapeutics wants to take the lead in a genetic iron disease, delivering midphase data on a hormone replacement therapy it envisages offering an alternative to blood draws. read more Sponsored by: Q2 Solutions Clinical lab testing at home - fact or fiction? Many operational and patient-related considerations must be taken when using a decentralized approach to specimen collection at or near the trial participant's home. read more By Nick Paul Taylor Twist Bioscience has found a path forward for its COVID-19 antibody program, spinning the project out to form startup Revelar Biotherapeutics and committing to invest up to $10 million in seed funding. read more By Kyle LaHucik Recludix Pharma wants to launch a class of STAT inhibitors that are more selective and more effective than JAK inhibitors in treating cancers and inflammatory diseases. The new biotech gets $60 million to start and 15-year Seagen executive Nancy Whiting in the CEO perch. read more By Conor Hale The company’s Aveir system aims to provide ventricular pacing on-demand—triggering an electrical pulse only when needed to get a slowing heart back on track, instead of a constant cadence. read more By Dave Muoio The rule aimed to cut down the time between regulatory authorization and Medicare coverage determination for innovative technologies. It was finalized days before Biden took office. read more By Arlene Weintraub A Northwestern team developed an injectable liquid containing modified peptides, which form nanofibers similar to the spinal cord’s extracellular matrix. In mouse models of spinal cord injury, the therapy promoted the regrowth of axons and restored walking ability, they said. read more Resources Sponsored by: Thermo Scientific Production Chemicals and Services Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific Sponsored by: Medable, Inc. Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper. Sponsored by: IQVIA Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making. Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Blue Matter Consulting Paper describing how the chronic insomnia market offers big lessons for any biopharma company thinking about getting into digital therapeutics in any therapeutic area. Sponsored by: TransPerfect Life Sciences Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper. Sponsored by: Informa Pharma Intelligence and Oracle Health Sciences New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic. Sponsored by: Thermo Fisher Scientific Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Pharma Meeting Pros Summit November 3-4, 2021 | Atlantic City, NJ & Virtual Drug Development Boot Camp® 2021 VIRTUAL November 17-18, 2021 Learn impact of pricing, competitive assessment, epidemiology November 17-18, 2021 | Live & Online Fierce New Product Planning Summit December 1-2, 2021 | Boston, MA Fierce Launch Readiness for Medical Affairs & Communications Teams December 1-2, 2021 | Boston, MA Learn how therapeutics are successfully launched and commercialized December 1-2, 2021 | Live & Online 2nd Annual Symposium on Translational Medicine and Biomanufacturing December 2—3, 2021 Fierce Virtual Clinical Trials Summit December 6-7, 2021 | Philadelphia, PA Fierce JPM Week 2022 January 11, 2022 | San Francisco, CA
January 18-20, 2022 | Virtual Event Virtual European Healthcare Compliance Certificate Program January 24-28, 2022 Fierce Pharma Drug Safety Summit February 8-9, 2022 | Location TBD Fierce Business Development and Licensing Summit March 15, 2022 | San Francisco, CA Fierce Medical Affairs Strategic Summit (MASS) East April 2022 | New Jersey Fierce Trial Master File Summit May 2022 | Location TBD Fierce Promotional Review Committee Compliance and Best Practices Summit April 2022 | New Jersey Fierce Digital Pharma Innovation Week June 2022 | Virtual Event Fierce Pharma PR & Communications Summit July 2022 | Location TBD (NYC Metro Area) Fierce Biotech Forum October 2022 | Location TBD | 